On August 15, 2022, Rocgene (Beijing) Technology Co., Ltd. (abbreviation: Rocgene) and China Bio Shanghai Jienuo Biotechnology Co., Ltd. (abbreviation: Zhongsheng Jienuo) formally reached a strategic
Host residual DNA detectionhas never been easierBiopharmaceutical products, whether they are antibodies, vaccines or cell gene therapy drugs, usually require host cells as carriers in their production
On August 15, 2022, Rocgene (Beijing) Technology Co., Ltd. (abbreviation: Rocgene) and China Bio Shanghai Jienuo Biotechnology Co., Ltd. (abbreviation: Zhongsheng Jienuo) formally reached a strategic
Host residual DNA detectionhas never been easierBiopharmaceutical products, whether they are antibodies, vaccines or cell gene therapy drugs, usually require host cells as carriers in their production
Both soft and hard Rocgene product technology in-depth trainingSince 2022, Rocgene "Little Ami" has become a new star product in the IVD industry, covering Zhejiang, Jiangsu, Shandong, Guangdong, He
Love must be expressed with actions RocgeneEasy series of consumables~Special love for a special you~ On this special day, Rocgene arranged exclusive benefits for little Ami's old friends.
The fate of a throat swabAs the "top stream" in recent years, the new crown pneumonia has been "running" one after another around the world, and it has achieved a level that no one knows about. Nuclei
Xuzhou mayor and his partyVisit the Rocgene production baseOn the afternoon of April 14, Wang Jianfeng, deputy secretary of the Xuzhou Municipal Party Committee and mayor, led a team to visit the Rocg
Recently, Gong Weifang, Deputy Mayor of Xuzhou City and Secretary of Tongshan District Committee, and his party went to Rocgene Xuzhou Production Base to exchange views on the production of epidemic p
On February 18, Professor Wang Hualiang, President of Shanghai Institute of Experimental Medicine, Chairman of the Experimental Medicine Branch of the National Health Industry Business Management Asso
